广西柳药集团股份有限公司 信息披露暂缓与豁免业务管理制度 （2025 年 8 月修订） 第一章 总 则 第一条 为规范广西柳药集团股份有限公司（以下简称"公司"）信息披露暂 缓与豁免行为，确保公司依法合规履行信息披露义务，保护投资者的合法权益， 根据《中华人民共和国证券法》 《上市公司信息披露暂缓与豁免管理规定》 《上海 证券交易所股票上市规则》（以下简称"《股票上市规则》"）《上海证券交易所上 市公司自律监管指引第 2 号——信息披露事务管理》等法律、法规、规范性文件 和《广西柳药集团股份有限公司章程》（以下简称"《公司章程》"）等有关规定， 结合公司实际情况，制定本制度。 第二条 公司和其他信息披露义务人暂缓、豁免披露临时报告，在定期报告、 临时报告中豁免披露中国证券监督管理委员会和上海证券交易所（以下简称"证 券交易所"）规定或者要求披露的内容，适用本制度。 第三条 公司和其他信息披露义务人应当真实、准确、完整、及时、公平地 披露信息，不得滥用暂缓或者豁免披露规避信息披露义务、误导投资者，不得实 施内幕交易、操纵市场等违法行为。 第四条 公司应当披露的信息存在《股票上市规则》及证券交易所其他相关 业务规 ...

Core Points - The article outlines the information disclosure deferral and exemption system of Lianhua Holdings Co., Ltd, aiming to ensure compliance with legal obligations and protect investors' rights [1][5] - The system is established based on various laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1][5] Group 1: General Principles - The company must comply with the Stock Listing Rules and other relevant regulations when handling information disclosure deferrals and exemptions [1][2] - The company has the discretion to determine if information can be deferred or exempted based on specific criteria outlined in the Stock Listing Rules [1][2] Group 2: Conditions for Deferral and Exemption - Information can be deferred if it is uncertain, classified as temporary business secrets, or if timely disclosure could harm the company's interests or mislead investors [2][4] - Information that is classified as state secrets or business secrets may be exempted from disclosure to avoid violating confidentiality laws [2][4] Group 3: Internal Management Procedures - Departments or subsidiaries must submit a formal application for deferral or exemption to the Securities Affairs Department, ensuring the accuracy and completeness of the information [3][4] - The Secretary of the Board is responsible for registering deferral or exemption requests, which must include details such as the content, reasons, and duration of the deferral [3][4] Group 4: Monitoring and Disclosure Obligations - The company must monitor the status of deferred or exempted information and disclose it promptly if certain conditions arise, such as leaks or abnormal trading activity [4][5] - If the reasons for deferral or exemption are resolved, the company must announce the relevant information and the circumstances surrounding the deferral or exemption [4][5] Group 5: Accountability and Penalties - The company has established a mechanism for accountability regarding information disclosure deferrals and exemptions, holding responsible parties accountable for violations [4][5] - Any failure to disclose information that meets the criteria for timely disclosure can lead to penalties for those directly responsible [4][5]

General Principles - The company establishes a system for the temporary suspension and exemption of information disclosure to ensure compliance with laws and regulations, protecting the rights of shareholders, creditors, and stakeholders [1][2] - The company can independently assess the need for temporary suspension or exemption of information disclosure without prior application to the Shanghai Stock Exchange, subject to post-event supervision [1][2] Scope of Temporary Suspension and Exemption - The company must disclose significant events promptly when certain conditions are met, such as board resolutions or when key personnel become aware of the events [2] - If a significant event is difficult to keep confidential or has already leaked, the company must disclose relevant information within two trading days [2] - The company can temporarily suspend disclosure if it may harm its interests or mislead investors, provided that confidentiality agreements are in place [2][3] Confidential Information - Information involving state secrets or commercial secrets can be exempted from disclosure if it meets specific criteria, such as potential harm from disclosure [3][4] - The company must disclose any temporarily suspended or exempted information once the reasons for suspension are eliminated or if the information becomes difficult to keep confidential [4][5] Review Procedures - The company must follow internal review procedures before deciding on temporary suspension or exemption of information disclosure, ensuring that the scope is not arbitrarily expanded [5][6] - A detailed internal registration and approval form must be completed for any information that is temporarily suspended or exempted, including reasons and potential impacts [5][6] Reporting Obligations - The company is required to submit relevant registration materials regarding temporarily suspended or exempted disclosures to regulatory authorities within ten days after the publication of periodic reports [6][7] Implementation and Amendments - The system will be effective upon approval by the board of directors and will be amended as necessary, adhering to national laws and regulations [7][8]

General Overview - The document outlines the information disclosure management system for Jiangsu Kangwei Century Biotechnology Co., Ltd, focusing on the procedures for deferring and exempting information disclosure obligations [2][3]. Information Disclosure Deferral and Exemption - The company can defer or exempt information disclosure without applying to the Shanghai Stock Exchange if the information falls under specific conditions outlined in the listing rules [3]. - Information that involves trade secrets or confidential business information can be deferred or exempted if it meets certain criteria, such as potential harm to the company or others if disclosed [3][4]. Criteria for Deferral and Exemption - The criteria for deferring or exempting disclosure include: 1. Disclosure of core technology information that may lead to unfair competition. 2. Disclosure of operational information that could infringe on the commercial secrets of the company or third parties. 3. Other situations where disclosure could severely harm the interests of the company or others [3][4]. Responsibilities and Procedures - The company must maintain strict confidentiality regarding state secrets and cannot use the excuse of confidentiality to promote business [3][4]. - A mechanism for accountability is established for any failure to report deferral or exemption matters in a timely manner, with potential penalties for responsible individuals [4][5]. Documentation and Record-Keeping - The company is required to keep detailed records of any deferral or exemption actions, including the reasons and internal review processes, for a minimum of ten years [4][5]. - Specific forms and documentation are outlined for the approval process of deferring or exempting disclosures, including a confidentiality commitment from individuals aware of the information [5][8].

Core Points - The article outlines the information disclosure and exemption management system of Wuxi Xiangsheng Medical Technology Co., Ltd, aiming to ensure compliance with legal obligations and protect investors' rights [1][2] - The company is required to disclose information in accordance with relevant regulations, but may defer or exempt disclosure under specific circumstances [1][2] - The internal management procedures for deferring or exempting disclosures are detailed, including the roles of the board of directors and the secretary [4][5] Chapter Summaries Chapter 1: General Principles - The system is established to regulate information disclosure and exemption behaviors, ensuring compliance with laws and protecting investor rights [1] - The company must assess whether information can be deferred or exempted based on specific criteria outlined in the regulations [1][2] Chapter 2: Applicable Situations and Conditions - Information may be exempted from disclosure if it involves state secrets or commercial secrets that could lead to unfair competition or harm to the company or others [2] - If the reasons for deferring or exempting disclosure are eliminated, the company must promptly disclose the information [2] Chapter 3: Internal Management Procedures for Disclosure Deferral and Exemption - The board of directors leads the management of deferral and exemption matters, with the secretary coordinating the process [4] - A formal application process is required, including documentation and internal approvals before any deferral or exemption is enacted [5] Chapter 4: Responsibilities and Penalties - The company must establish a responsibility accountability mechanism for any non-compliance with the disclosure system [6][7] - Individuals responsible for improper deferral or exemption may face consequences if it leads to negative impacts on the company or investors [7] Chapter 5: Supplementary Provisions - The system must align with existing stock exchange rules and relevant laws [7] - The board of directors is responsible for interpreting the system, which takes effect upon approval [7]

《上海证券交易所科创板股票上市规则》 （以下简称"《上 市规则》"）和《公司章程》及其他有关规定，结合公司实际 情况，制定本制度。 成都华微电子科技股份有限公司 信息披露暂缓与豁免业务管理制度 第二条 公司和其他信息披露义务人按照《上市规则》及上 海证券交易所（以下简称"交易所"）其他相关业务规则的规 定，实施信息披露暂缓、豁免业务的，适用本制度。 第一章 总则 第一条 为规范成都华微电子科技股份有限公司（以下简称 "公司"）的信息披露暂缓与豁免行为，促进公司依法规范运 作，维护公司及投资者的合法权益，依据《中华人民共和国证 券法》 第三条 公司和其他信息披露义务人拟披露的信息存在《上 市规则》规定的暂缓、豁免情形的，可以无须向交易所申请， 由公司自行审慎判断，并接受交易所对有关信息披露暂缓、豁 免事项的事后监管。 第二章 暂缓、豁免披露信息的范围 （一） 暂缓、豁免披露原因已消除； （二） 有关信息难以保密； （三） 有关信息已经泄露或者市场出现传闻。 第八条 公司拟披露的定期报告中有关信息涉及国家秘密、 商业秘密的，可以采用代称、汇总概括或者隐去关键信息等方 式豁免披露该部分信息。 公司和其他信息披露义务 ...

塞力斯医疗科技集团股份有限公司 信息披露暂缓与豁免管理制度 第五条 公司和其他信息披露义务人有确实充分的证据证明拟披露的信息 涉及国家秘密或者其他因披露可能导致违反国家保密规定、管理要求的事项（以 下统称"国家秘密"），依法豁免披露。 第六条 公司和其他信息披露义务人有保守国家秘密的义务，不得通过信 息披露、投资者互动问答、新闻发布、接受采访等任何形式泄露国家秘密，不 得以信息涉密为名进行业务宣传。 公司的董事长、董事会秘书应当增强保守国家秘密的法律意识，保证所披露 塞力斯医疗科技集团股份有限公司 信息披露暂缓与豁免管理制度 的信息不违反国家保密规定。 塞力斯医疗科技集团股份有限公司 信息披露暂缓与豁免管理制度 （2025 年 8 月） 第一条 为了规范塞力斯医疗科技集团股份有限公司（以下简称"公司"） 信息披露暂缓与豁免行为，明确公司及相关信息披露义务人依法合规履行信息 披露义务，保护投资者的合法权益，根据《中华人民共和国公司法》《中华人 民共和国证券法》《上市公司信息披露暂缓与豁免管理规定》《上海证券交易 所股票上市规则》等法律法规、规章、规范性文件以及《塞力斯医疗科技集团 股份有限公司章程》（以下简称" ...

Core Viewpoint - The article outlines the information disclosure management system of Jiangxi Tianxin Pharmaceutical Co., Ltd., emphasizing the importance of protecting national secrets and commercial confidentiality while ensuring compliance with relevant laws and regulations [2][4]. Group 1: General Principles - The company establishes this system to regulate the deferral and exemption of information disclosure, ensuring compliance with the Company Law, Securities Law, and other relevant regulations [2]. - The company is responsible for determining whether information can be deferred or exempted from disclosure based on specific criteria [2][3]. Group 2: Scope of Deferred and Exempted Information - Information that involves national secrets or could violate confidentiality regulations may be exempted from disclosure [2][3]. - Commercial secrets can be deferred or exempted from disclosure if they meet certain conditions, such as being core technology information that could lead to unfair competition [2][3]. Group 3: Review Procedures for Deferral and Exemption - Individuals aware of the information must limit its disclosure to a minimum number of people until a decision is made regarding deferral or exemption [3]. - The company must maintain a record of any deferred or exempted information, including the type of report and the reasons for deferral or exemption [3][4]. Group 4: Responsibilities and Penalties - The company will impose penalties on individuals responsible for failing to disclose information that should have been disclosed after the reasons for deferral or exemption have ceased [4][5]. - The company must ensure that all information provided for deferral or exemption is truthful, accurate, and complete [4].

General Provisions - The company establishes a system for the temporary suspension and exemption of information disclosure to ensure compliance with legal obligations and internal regulations [1][2] - The company must disclose information truthfully, accurately, completely, timely, and fairly, avoiding misuse of suspension or exemption to mislead investors [2][3] Scope and Conditions for Suspension and Exemption - The company should carefully determine the scope of information that can be temporarily suspended or exempted from disclosure, maintaining consistency with the initial listing conditions [4][5] - Information involving state secrets can be exempted from disclosure if there is sufficient evidence proving that disclosure would violate confidentiality regulations [5][6] - Business secrets can be temporarily suspended or exempted from disclosure if they fall under specific conditions that could lead to unfair competition or harm to the company or others [6][7] Internal Procedures and Reporting - The company must follow an internal approval process for any temporary suspension or exemption of disclosure, which includes documentation and archiving for ten years [5][6] - The company is required to report any temporary suspension or exemption of disclosure to the relevant regulatory bodies within ten days after the announcement of periodic reports [6][7] Additional Provisions - The company must revise the system as necessary to align with national laws and regulations, ensuring that any conflicts are resolved according to legal standards [8][9] - The board of directors is responsible for interpreting the system and ensuring its effective implementation [8]

深圳光峰科技股份有限公司 信息披露暂缓与豁免事务管理制度 （2025 年 8 月修订） 第一章 总 则 第四条 公司和其他信息披露义务人应当真实、准确、完整、及时、公平地 披露信息，不得滥用暂缓或者豁免披露规避信息披露义务、误导投资者，不得实 施内幕交易、操纵市场等违法行为。 第五条 公司和其他信息披露义务人有确实充分的证据证明拟披露的信息 涉及国家秘密或者其他因披露可能导致违反国家保密规定、管理要求的事项（以 下统称"国家秘密"），依法豁免披露。 本制度所称"国家秘密"，是指国家有关保密的法律法规及部门规章规定 的，关系国家安全和利益，依照法定程序确定，在一定时间内只限一定范围的人 员知悉，泄露后可能损害国家在政治、经济、国防、外交等领域的安全和利益的 信息，以及其他中国证监会、上交所认定的国家秘密。公司和其他信息披露义务 人有保守国家秘密的义务，不得通过信息披露、投资者互动问答、新闻发布、接 受采访等任何形式泄露国家秘密，不得以信息涉密为名进行业务宣传。 第六条 公司和其他信息披露义务人拟披露的信息涉及商业秘密或者保密 商务信息（以下统称"商业秘密"），符合下列情形之一，且尚未公开或者泄露 的，可以暂缓或 ...